Very recently, Günther et al. introduced [99mTc]Tc-N4-BTG, a novel pharmacophore-modified GRPR-directed vector for conventional nuclear medicine imaging, which revealed noticeably improved tumour-to-organ ratios in animals when compared to other bombesin derivatives. Here, GRPR is linked to neoplasm.